Login / Signup
Hongyuan Mou
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Mouse Model
Cancer Therapy
Patient Reported Outcomes
Pi K Akt
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Daoyan Wei
,
Dongmei Chen
,
Hongyuan Mou
,
Sharmistha Chakraborty
,
Bo Wei
,
Lin Tan
,
Philip L Lorenzi
,
Xiangping Qian
,
Peiying Yang
Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma.
Molecular cancer therapeutics
(2023)